More than a dozen autoimmune diseases can attack the eyes, and no single condition holds that distinction alone. The most common culprits include uveitis linked to HLA-B27 and spondyloarthritis, Graves’ disease (thyroid eye disease), Sjögren’s syndrome, Behçet’s disease, Vogt-Koyanagi-Harada disease, and the optic neuritis seen in multiple sclerosis and related disorders. Each targets a different part of the eye through a different immune pathway, so the symptoms, severity, and treatment vary widely.
Why the Eye Is Vulnerable
The eye has long been considered an “immune-privileged” site, meaning it actively suppresses local immune and inflammatory responses to protect delicate structures like the retina and cornea that cannot easily regenerate.1PubMed Central. Ocular immune privilege That privilege works most of the time, but when it breaks down, the consequences can be severe. Immune cells that would cause only mild trouble in a joint or on the skin can cause scarring, swelling, or permanent vision loss inside the eye. The eye also contains unique proteins and pigment-producing cells (melanocytes) that, in certain autoimmune conditions, become direct targets for the immune system.
Uveitis and the HLA-B27 Connection
Uveitis, or inflammation inside the eye, is among the most common ways autoimmune disease shows up in ophthalmology. When it strikes the front of the eye (acute anterior uveitis), you get sudden redness, pain, light sensitivity, and blurred vision, often in just one eye at a time. One of the strongest known genetic links to any autoimmune condition ties this form of uveitis to the HLA-B27 gene, a marker that also connects to ankylosing spondylitis, reactive arthritis, and inflammatory bowel disease.2PubMed. Acute anterior uveitis and HLA-B27 If you carry HLA-B27 and develop a red, painful eye, an ophthalmologist will consider uveitis high on the list.
Genome-wide studies have confirmed that anterior uveitis is a polygenic disease with substantial genetic overlap with spondyloarthritis and inflammatory bowel disease.3PubMed Central. Recent Developments in HLA B27 Anterior Uveitis This overlap explains why many people with uveitis also develop back pain or gut symptoms over time, and why rheumatologists and ophthalmologists frequently co-manage these patients. Episodes tend to recur, and each flare carries a cumulative risk of complications like cataracts, glaucoma, or macular edema.
Thyroid Eye Disease
Graves’ disease, the most common cause of hyperthyroidism, produces a distinct and often disfiguring form of eye involvement known as thyroid eye disease (TED). The immune system generates antibodies that bind to receptors on cells behind the eye, particularly the TSH receptor and the IGF-1 receptor, triggering inflammation and tissue expansion in the eye socket.4Heliyon. Comparison of orbital fibroblasts from Graves’ ophthalmopathy and healthy control The result is bulging eyes (proptosis), double vision, eyelid retraction, and in severe cases, compression of the optic nerve.
TED has been notoriously difficult to treat, but the approval of teprotumumab, a monoclonal antibody that blocks the IGF-1 receptor, changed the landscape. In a randomized trial, about 83% of patients treated with teprotumumab achieved a meaningful reduction in eye bulging at 24 weeks, compared with 10% on placebo.5PubMed. Teprotumumab for the Treatment of Active Thyroid Eye Disease Follow-up data showed that patients who initially received placebo responded just as well when later given teprotumumab, and responses held up at 48 weeks in most patients.6PubMed. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study A trial in Japanese patients confirmed similarly high response rates.7The Lancet Regional Health—Western Pacific. A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients Before teprotumumab, the main options were steroids, orbital radiation, and decompression surgery, so this represented a genuine breakthrough for patients living with the condition.
Sjögren’s Syndrome and Chronic Dry Eye
Sjögren’s syndrome is a chronic autoimmune disease in which immune cells infiltrate and gradually destroy the glands that produce tears and saliva.8PubMed. Primary Sjögren’s syndrome and the eye The hallmark eye problem is keratoconjunctivitis sicca, a form of dry eye far more severe and persistent than the dryness most people experience from screen time or dry air. The cornea can become damaged, and without adequate tear film, you are more susceptible to infections and corneal ulcers.9PubMed Central. Ophthalmologic Manifestations of Primary Sjögren’s Syndrome
The severity varies widely. Some people manage with artificial tears and punctal plugs. Others develop corneal scarring or need more aggressive immunosuppression. Sjögren’s can occur on its own (primary) or alongside other autoimmune diseases like rheumatoid arthritis or lupus (secondary), and the eye involvement tends to be present in both forms. Because dryness builds slowly, many patients live with it for years before getting a formal diagnosis.
Behçet’s Disease
Behçet’s disease is a systemic vasculitis, meaning it inflames blood vessels throughout the body, and the eye is one of its most dangerous targets. The typical ocular presentation is a relapsing, bilateral panuveitis with retinal vasculitis, meaning the inflammation involves both the front and back of the eye and damages the blood vessels feeding the retina.10PubMed Central. Ocular Manifestations of Behçet’s Disease: An Update on Diagnostic Challenges and Disease Management Only about 10% of patients, mostly women, present with isolated anterior uveitis; the rest face posterior or pan-ocular disease that can lead to rapid vision loss if untreated.
Behçet’s is most common along the ancient Silk Road, from East Asia through the Middle East to the Mediterranean. It classically produces oral ulcers, genital ulcers, and skin lesions alongside the eye inflammation, which helps distinguish it from other causes of uveitis. Aggressive immunosuppression, often with drugs like azathioprine, cyclosporine, or biologics such as infliximab, is typically needed to prevent blindness.
Vogt-Koyanagi-Harada Disease
Vogt-Koyanagi-Harada disease (VKH) is an autoimmune attack on melanocytes, the pigment-producing cells found in the eye, skin, inner ear, and meninges. It is driven by T-cells in people who carry a specific genetic marker, the HLA-DRB1*0405 allele, and often follows a viral trigger.11PubMed Central. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes In the eye, VKH causes bilateral granulomatous uveitis with exudative retinal detachments. Beyond the eyes, patients may develop hearing changes, headaches from meningeal inflammation, and skin depigmentation (vitiligo) or premature graying of the hair.12PubMed Central. Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals
VKH is more common in people of Asian, Middle Eastern, Hispanic, and Native American descent. Early, aggressive treatment with high-dose corticosteroids and steroid-sparing immunosuppressants is critical. The disease can smolder chronically, and repeated flares damage the retina and optic nerve over time.
Multiple Sclerosis, NMOSD, and MOGAD
Optic neuritis, an inflammatory attack on the optic nerve, is a well-known feature of multiple sclerosis (MS) and is often the first symptom that leads to a diagnosis.13PubMed Central. The Diagnosis and Treatment of Optic Neuritis It typically presents as sudden, painful loss of vision in one eye, usually with pain on eye movement. In MS, most people recover much of their vision after an episode, though subtle deficits often persist.
Two related but distinct conditions, neuromyelitis optica spectrum disorder (NMOSD, driven by antibodies against the AQP4 water channel) and MOG antibody-associated disease (MOGAD), also cause optic neuritis but tend to be more severe. A meta-analysis found that eyes affected by AQP4-antibody optic neuritis had worse visual outcomes than those from MS or MOG-antibody optic neuritis, with more severe thinning of the retinal nerve fiber layer.14PubMed Central. AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis Researchers have also shown that AQP4-positive and MOG-positive disease damage the optic nerve through different mechanisms, with distinct patterns of blood flow changes in the optic nerve head.15Scientific Reports. Differentiation of acute-phase AQP4-IgG+ optic neuritis from CNS inflammatory diseases using optic nerve head blood flow analysis Distinguishing between these three conditions matters because their treatments differ: the immunosuppressants that work well for NMOSD can be ineffective or harmful in MS, and vice versa.
Rheumatoid Arthritis, Pemphigoid, and Other Connective Tissue Diseases
Rheumatoid arthritis (RA) can cause scleritis, a deep and painful inflammation of the sclera (the white outer coat of the eye). Scleritis linked to RA is not trivial: nearly two-thirds of patients with non-infectious scleritis need systemic steroids, and about a quarter need additional immunosuppressive therapy.16ScienceDirect. Scleritis and peripheral ulcerative keratitis RA can also cause peripheral ulcerative keratitis, a condition where the edge of the cornea thins and erodes, which almost always requires systemic treatment. These complications tend to appear in people with longstanding, poorly controlled disease, and their presence signals aggressive systemic inflammation.
Ocular cicatricial pemphigoid (OCP) is a rarer autoimmune condition in which antibodies attack the basement membrane of the conjunctiva, the tissue lining the inside of the eyelids. Over time, this causes progressive scarring, eyelid deformity, and corneal damage that can lead to permanent vision loss.17PubMed Central. Ocular cicatricial pemphigoid OCP progresses slowly enough that early stages are easily missed, making regular eye exams important for anyone diagnosed with mucous membrane pemphigoid.
When Surgery or Trauma Triggers an Autoimmune Response
Sympathetic ophthalmia is a rare but dramatic example of autoimmune eye disease triggered by a specific event. After penetrating trauma or intraocular surgery to one eye, the immune system can become sensitized to ocular proteins it had never encountered before. Weeks to months later, the uninjured eye develops a severe granulomatous inflammation.18PubMed Central. Update on sympathetic ophthalmia Patients notice blurred vision, pain, and light sensitivity in the eye that was never touched. Without treatment, sympathetic ophthalmia can blind both eyes.19PubMed Central. Sympathetic ophthalmia: A comprehensive update This is one reason surgeons take great care to repair or, in some cases, remove a severely damaged eye promptly.
Childhood Uveitis and Juvenile Idiopathic Arthritis
Children are not spared from autoimmune eye disease. Juvenile idiopathic arthritis (JIA) is the most common chronic childhood arthritis, and its most feared extra-articular complication is chronic anterior uveitis. Unlike the adult form, JIA-associated uveitis is typically painless and causes no redness, so a child may have active inflammation for months before anyone notices a problem.20PubMed Central. Juvenile idiopathic arthritis-associated uveitis By the time symptoms like blurred vision appear, significant damage may have already occurred. For this reason, American College of Rheumatology guidelines strongly recommend regular eye screening for all children with JIA, with the frequency tailored to individual risk factors like age at onset and the presence of antinuclear antibodies.21PubMed Central. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis
What Raises the Risk of Vision Loss
Not every episode of autoimmune eye inflammation leads to permanent damage, but certain factors tip the odds. In a study of adult uveitis patients, about 44% developed at least one complication over follow-up, with cataracts, iris changes, and macular edema topping the list. Age 65 or older, a chronic disease course, and active inflammation lasting more than three months were all independent predictors of complications.22PubMed. Risk factors for ocular complications in adult patients with uveitis The message is consistent across conditions: the longer inflammation burns, the more collateral damage accumulates. Early and sustained control of inflammation is the single most important factor in preserving vision.
How Doctors Tell These Conditions Apart
Because so many autoimmune diseases can inflame the eye, reaching the right diagnosis requires more than just an eye exam. Ophthalmologists use slit-lamp examination, dilated fundoscopy, and increasingly sophisticated imaging like optical coherence tomography (OCT), which can reveal characteristic patterns of retinal thinning or swelling that help narrow the possibilities.23PubMed Central. Optical coherence tomography findings in autoimmune retinopathy Blood tests for specific antibodies (AQP4-IgG, MOG-IgG, antinuclear antibodies, HLA-B27 typing) and markers of systemic inflammation help distinguish among overlapping conditions.24PubMed Central. Immunological tests and their interpretation in uveitis Getting the diagnosis right matters enormously because treatments are not interchangeable: the drug that controls Behçet’s uveitis may do nothing for thyroid eye disease, and the biologic that reverses proptosis in Graves’ disease has no role in Sjögren’s dry eye.
Biologics and Evolving Treatments
Beyond teprotumumab for thyroid eye disease, biologic therapies are reshaping treatment for several autoimmune eye conditions. Rituximab, which depletes a population of immune cells called B-cells, has shown strong results in non-infectious uveitis that resists conventional immunosuppression. A review of the evidence found that about 80% of patients achieved resolution of ocular inflammation after rituximab, with roughly 44% seeing improvement in visual acuity, and over 80% able to reduce their steroid doses.25PubMed Central. Rituximab in the Treatment of Non-Infectious Uveitis: A Review TNF-alpha inhibitors like infliximab and adalimumab have become standard for conditions like Behçet’s uveitis and JIA-associated uveitis, and newer agents targeting specific interleukins are in development. The overall trajectory is moving away from blunt, whole-immune-system suppression toward more targeted approaches that control inflammation while sparing the patient from some of the worst side effects of chronic steroids.
Cancer Immunotherapy as an Unintended Trigger
An increasingly recognized source of autoimmune eye problems is cancer immunotherapy. Immune checkpoint inhibitors, drugs that release the brakes on the immune system to fight tumors, can inadvertently unleash the immune system against normal tissues, including the eye. Reported ocular side effects include dry eye, uveitis, retinal vasculitis, and optic neuropathy.26PubMed Central. Emerging Ocular Side Effects of Immune Checkpoint Inhibitors: A Comprehensive Review These complications are uncommon, but as checkpoint inhibitors become more widely used in oncology, ophthalmologists are seeing more cases. The challenge lies in managing the eye inflammation without undermining the cancer treatment, which often requires close coordination between oncologists and eye specialists.
The Gut-Eye Connection
One of the more surprising research threads links gut bacteria to autoimmune eye disease. In animal models, mice raised in germ-free conditions or treated with broad-spectrum antibiotics developed less severe experimental uveitis, suggesting that gut bacteria play a role in driving the immune response that attacks the eye.27PubMed Central. Uveitis and the gut microbiota Studies in human uveitis patients have also found differences in the composition of gut bacteria compared to healthy controls. Several mechanisms have been proposed: gut bacteria might produce proteins that resemble eye proteins (antigenic mimicry), or an imbalanced gut microbiome might disrupt immune regulation more broadly, reduce anti-inflammatory metabolites, and compromise the intestinal barrier.28PubMed. The Role of Gut Microbiome in Autoimmune Uveitis This research is still early, and no one is prescribing probiotics for uveitis yet, but it points toward an unexpected connection between digestive health and eye inflammation.
The Psychological Weight of Autoimmune Eye Disease
Living with a condition that threatens your vision takes a psychological toll that often goes unaddressed. In a study of patients with autoimmune eye diseases, physical quality of life was markedly reduced, and about half were recommended for structured psychological support or psychotherapy based on integrated assessment.29PubMed Central. When eye disease affects the mind: Psychological burden and functioning in autoimmune ophthalmology Research focused specifically on thyroid eye disease found that 42% of patients reported anxiety or depression, more than double the rate in the general adult population, and quality-of-life scores were heavily affected by both the appearance changes and the visual function limitations of the disease.30PubMed Central. Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States Appearance-related distress is particularly prominent in TED, where bulging eyes and eyelid changes are visible to others. These findings underscore that managing autoimmune eye disease well means paying attention not only to inflammation and vision but also to the patient’s mental health and daily functioning.